Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLDD
426
DELISTED
Great Lakes Dredge & Dock
GLDD
| $17.2M | 0.02% |
4,091,923
-777,912
| -16% | -$3.16M |
|
427
Enterprise Products Partners
EPD
$83.6B
| $17M | 0.02% |
630,252
+37,747
| +6% | +$983K |
|
|
TIVO
428
DELISTED
Tivo Inc
TIVO
| $16.9M | 0.02% |
808,653
-121,066
| -13% | -$2.46M |
|
|
TEP
429
DELISTED
Tallgrass Energy Partners, LP
TEP
| $16.8M | 0.02% |
354,865
+23,314
| +7% | +$1.08M |
|
|
GWPH
430
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $16.7M | 0.02% |
149,419
+461
| +0.3% | +$55.5K |
|
431
Weyerhaeuser
WY
$17.7B
| $16.5M | 0.02% |
+548,335
| New | +$16.9M |
|
|
NUVA
432
DELISTED
NuVasive, Inc.
NUVA
| $16.5M | 0.02% |
244,297
-127,861
| -34% | -$8.24M |
|
433
MPLX
MPLX
$60.1B
| $16.4M | 0.02% |
473,631
+225,665
| +91% | +$7.33M |
|
434
HubSpot
HUBS
$12.2B
| $16.1M | 0.02% |
343,043
+160,501
| +88% | +$8.5M |
|
435
Surgery Partners
SGRY
$2.04B
| $16.1M | 0.02% |
1,017,210
-201,573
| -17% | -$3.35M |
|
|
RMP
436
DELISTED
Rice Midstream Partners LP
RMP
| $16M | 0.02% |
652,010
+41,050
| +7% | +$915K |
|
437
Pinnacle West Capital
PNW
$12.8B
| $15.9M | 0.02% |
204,052
-313,035
| -61% | -$23.5M |
|
438
Commault Systems
CVLT
$4.97B
| $15.8M | 0.02% |
308,123
+287,604
| +1,402% | +$15.4M |
|
439
Monolithic Power Systems
MPWR
$63B
| $15.5M | 0.02% |
189,609
-164,985
| -47% | -$13.2M |
|
|
CORE
440
DELISTED
Core Mark Holding Co., Inc.
CORE
| $15.5M | 0.02% |
359,033
+145,210
| +68% | +$5.36M |
|
|
ITCI
441
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.5M | 0.02% |
1,024,366
-289,150
| -22% | -$4.08M |
|
442
Sarepta Therapeutics
SRPT
$1.63B
| $15.5M | 0.02% |
563,333
-830,455
| -60% | -$33.4M |
|
443
Insmed
INSM
$22.6B
| $15.4M | 0.02% |
1,167,439
+3,646
| +0.3% | +$49.7K |
|
444
Eldorado Gold
EGO
$8.4B
| $15.2M | 0.02% |
948,428
-310,551
| -25% | -$4.88M |
|
|
EEP
445
DELISTED
Enbridge Energy Partners
EEP
| $14.9M | 0.02% |
585,145
+20,689
| +4% | +$504K |
|
446
iShares Russell 1000 Growth ETF
IWF
$119B
| $14.8M | 0.02% |
566,220
+499,168
| +744% | +$13M |
|
447
Freeport-McMoran
FCX
$88.6B
| $14.5M | 0.02% |
1,097,485
-45,215
| -4% | -$578K |
|
|
BPL
448
DELISTED
Buckeye Partners, L.P.
BPL
| $14.5M | 0.02% |
218,680
+18,902
| +9% | +$1.25M |
|
|
NBLX
449
DELISTED
Noble Midstream Partners LP
NBLX
| $14.4M | 0.02% |
400,176
+97,938
| +32% | +$3.14M |
|
|
NVDQ
450
DELISTED
Novadaq Technologies Inc.
NVDQ
| $14.4M | 0.02% |
2,027,587
+36,037
| +2% | +$327K |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.